cells have been proved a promising immunotherapeutic strategy to fight cancer. Antibody
recruiting molecules (ARMs) combining tumor and antibody binding modules have been
developed for this purpose, however the formation of the interacting complex with both
antibody and cell is difficult to optimize to stimulate immune-mediated cytotoxicity. To
circumvent this limitation, we report herein a more direct approach combining cell …